Supergene, LLC   Report issue

For profit Phase 3
Founded: Moscow Russian Federation (2008)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2014
NCT02301910
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Supergene LCC | Supergene, LLC | Supergene LSS